Orthofix Medical Inc (NASDAQ: OFIX) on Monday, plunged -3.64% from the previous trading day, before settling in for the closing price of $11.25. Within the past 52 weeks, OFIX’s price has moved between $10.50 and $20.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 11.69% over the last five years. The company achieved an average annual earnings per share of 34.55%. With a float of $37.53 million, this company’s outstanding shares have now reached $39.10 million.
The firm has a total of 1616 workers. Let’s measure their productivity. In terms of profitability, gross margin is 66.08%, operating margin of -12.55%, and the pretax margin is -17.51%.
Orthofix Medical Inc (OFIX) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Orthofix Medical Inc is 4.20%, while institutional ownership is 87.27%. The most recent insider transaction that took place on May 09 ’25, was worth 125,400. In this transaction President & CEO of this company bought 10,000 shares at a rate of $12.54, taking the stock ownership to the 234,603 shares. Before that another transaction happened on May 12 ’25, when Company’s Director bought 2,000 for $12.59, making the entire transaction worth $25,172. This insider now owns 28,733 shares in total.
Orthofix Medical Inc (OFIX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 34.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 62.08% during the next five years compared to -17.02% drop over the previous five years of trading.
Orthofix Medical Inc (NASDAQ: OFIX) Trading Performance Indicators
Orthofix Medical Inc (OFIX) is currently performing well based on its current performance indicators. A quick ratio of 1.50 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.70, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.09 in one year’s time.
Technical Analysis of Orthofix Medical Inc (OFIX)
Analysing the last 5-days average volume posted by the [Orthofix Medical Inc, OFIX], we can find that recorded value of 0.5 million was better than the volume posted last year of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 16.74%. Additionally, its Average True Range was 0.53.
During the past 100 days, Orthofix Medical Inc’s (OFIX) raw stochastic average was set at 3.41%, which indicates a significant increase from 2.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.90% in the past 14 days, which was lower than the 36.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.50, while its 200-day Moving Average is $16.35. Now, the first resistance to watch is $11.10. This is followed by the second major resistance level at $11.36. The third major resistance level sits at $11.52. If the price goes on to break the first support level at $10.68, it is likely to go to the next support level at $10.52. Should the price break the second support level, the third support level stands at $10.26.
Orthofix Medical Inc (NASDAQ: OFIX) Key Stats
Market capitalization of the company is 424.72 million based on 39,181K outstanding shares. Right now, sales total 799,490 K and income totals -126,000 K. The company made 193,650 K in profit during its latest quarter, and -53,090 K in sales during its previous quarter.
